Cadrenal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 23, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	22	26	10	-
Market Cap Growth	239.36%	168.05%	-	-
Enterprise Value	15	21	1	-
Last Close Price	11.44	14.49	11.10	-
PB Ratio	3.57	3.47	1.25	-
P/TBV Ratio	3.68	3.47	1.25	-
Debt / Equity Ratio	-	-	0.00	-0.11
Quick Ratio	4.00	3.75	10.21	0.02
Current Ratio	4.32	3.77	10.27	0.55
Return on Equity (ROE)	-208.59%	-140.78%	-780.59%	-
Return on Assets (ROA)	-109.43%	-73.49%	-102.62%	-
Return on Capital (ROIC)	-133.24%	-90.41%	-340.35%	-
Earnings Yield	-57.04%	-41.24%	-86.73%	-
FCF Yield	-45.25%	-28.51%	-36.67%	-
Buyback Yield / Dilution	-43.28%	-35.59%	-70.99%	-

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q